Nektar Therapeutics(CH:NKTR)
CH:NKTR
Nektar Therapeutics earnings date
Nektar Therapeutics (NKTR) Q2 2022 Earnings Report
1 Followers
CH:NKTR Q2 2022 EPS Results
- Actual EPS
- -CHF 10.65
- Consensus EPS
- -CHF 12.15
- Beat/Miss
- Beat by +CHF 1.50
- One Year Ago EPS
- -CHF 8.65
CH:NKTR Q2 2022 Revenue Results
- Actual Revenue
- CHF 18.03M
- Expected Revenue
- CHF 18.89M
- Beat/Miss
- Missed by -CHF 862.02K
- YoY Revenue Growth
- -23.81%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- After Close
- Conference Call
- Thursday, August 4, 2022
CH:NKTR Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NKTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -2.08- | -1.49 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -1.73-1.36 | -1.56 | 12.83% (+0.20) | |
| Aug 13, 2026 | 2026 (Q2) | -1.65-1.03 | -2.46 | 58.31% (+1.44) | |
| May 07, 2026 | 2026 (Q1) | -1.32-1.52 | -3.01 | 49.44% (+1.49) | |
| Mar 12, 2026 | 2025 (Q4) | -2.07-1.49 | 0.38 | -495.56% (-1.86) | |
| Nov 06, 2025 | 2025 (Q3) | -2.24-1.56 | -2.26 | 30.74% (+0.69) | |
| Aug 07, 2025 | 2025 (Q2) | -2.53-2.46 | -3.13 | 21.33% (+0.67) | |
| May 08, 2025 | 2025 (Q1) | -2.14-3.01 | -2.38 | -26.32% (-0.63) | |
| Mar 12, 2025 | 2024 (Q4) | -1.700.38 | -2.76 | 113.64% (+3.13) | |
| Nov 07, 2024 | 2024 (Q3) | -2.49-2.26 | -3.01 | 25.00% (+0.75) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

